ACGN — Aceragen Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $3.20m
- $1.08m
- $4.86m
Annual cashflow statement for Aceragen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -59.9 | -56.5 | -113 | 98.1 | -23.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 6.25 | 15.2 | 79.9 | -123 | 4.38 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.28 | -3.26 | -1.12 | 0.388 | 0.787 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -51.9 | -44.5 | -33.8 | -24.6 | -24.5 |
| Capital Expenditures | -0.075 | -0.011 | -0.008 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.29 | -2.39 | -1.68 | 4.5 | 5.48 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.215 | -2.4 | -1.69 | 4.5 | 5.48 |
| Financing Cash Flow Items | — | 10.1 | — | 0 | -1.54 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.2 | 15.5 | 28.7 | 19.4 | -1.49 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -41.5 | -31.4 | -6.79 | -0.684 | -20.5 |